相关实验视频

Updated: Jan 7, 2026

Anti-Nuclear Antibody Screening Using HEp-2 Cells

Anti-Nuclear Antibody Screening Using HEp-2 Cells

Published on: June 23, 2014

在新诊断患有骨髓灰质炎的个体中,血清学检测模式

A Pesa Jacqueline¹, N Liberman Joshua², D Darer Jonathan²

¹Johnson & Johnson Innovative Medicine, 1125 Trenton Harbourton Rd, Titusville, NJ 08560, United States of America.

Journal of the neurological sciences

|December 27, 2025

概括

骨髓灰质炎 (MG) 诊断依赖于血清抗体检测. 现实数据显示,在美国,综合抗体测试的利用不足,特别是对乙胆受体 (anti-AChR),肌肉特异性激酶 (anti-MuSK) 和低密度脂蛋白受体相关蛋白4 (anti-LRP4) 的使用不足.

科学领域:

神经学神经学
免疫学免疫学免疫学
临床诊断临床诊断临床诊断

背景情况:

血清抗体检测对于诊断骨髓灰质炎 (MG) 和指导治疗策略至关重要.
了解现实世界的测试模式对于优化患者护理和诊断准确性至关重要.

研究的目的:

评估美国MG血清状况测试的当前模式.
确定影响患者接受MG血清检测的可能性的因素.

主要方法:

一项追溯的观察性队列研究分析了与血清学检测结果相关的保险索赔.
该研究包括2018年1月1日至2022年6月30日之间新诊断出MG的成年人.
血清状态测试包括乙胆受体 (anti-AChR),肌肉特异性激酶 (anti-MuSK) 和低密度脂蛋白受体相关蛋白4 (anti-LRP4) 抗体.

主要成果:

在5788名新诊断的MG患者中,只有44.7%的患者有有效的血清学结果.
在血清阴性患者中,很大一部分患者仅测试了抗AChR抗体,不经常测试抗MuSK和抗LRP4.
与更高的测试率相关的因素包括神经病诊断,MG症状,城市居住,较少的并发病和医疗保险.

结论:

美国各地的MG血清检测实践存在显著差异.
在血清阴性患者中,对MuSK和LRP4抗体的不频繁测试表明,在遵守最佳实践方面存在差距.
建议推广标准化和全面的抗体检测协议,以改善MG的诊断和管理.

关键词:

乙胆受体 (抗AChR) 抗体的抗体.低密度脂蛋白受体相关蛋白4 (抗LRP4) 抗体.肌肉特异性激酶受体 (anti-MuSK) 抗体.骨髓灰质炎 (Myasthenia gravis) 是一个严重的疾病.血清学测试测试血清学测试

更多相关视频

Simultaneous Distinction of Monospecific and Mixed DFS70 Patterns During ANA Screening with a Novel HEp-2 ELITE/DFS70 Knockout Substrate

Simultaneous Distinction of Monospecific and Mixed DFS70 Patterns During ANA Screening with a Novel HEp-2 ELITE/DFS70 Knockout Substrate

Published on: January 17, 2018

Antigenic Liposomes for Generation of Disease-specific Antibodies

Antigenic Liposomes for Generation of Disease-specific Antibodies

Published on: October 25, 2018

相关概念视频

Myasthenia Gravis: Diagnostic Tests

Myasthenia Gravis: Diagnostic Tests

Myasthenia gravis is an autoimmune condition affecting neuromuscular transmission, causing generalized weakness in skeletal muscles. Initial diagnoses rely on patients' signs, symptoms, and medical history. The challenge lies in distinguishing myasthenia from other muscular dystrophies. An important diagnostic feature is the significant improvement of symptoms after administering anticholinesterase inhibitors.
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...

Myasthenia Gravis: Overview and Treatment

Myasthenia Gravis: Overview and Treatment

Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...

Myocarditis II: Clinical Features and Diagnostic Tests

Myocarditis II: Clinical Features and Diagnostic Tests

Myocarditis is an inflammation of the heart muscle. The symptoms vary widely, encompassing asymptomatic presentations to severe, acute manifestations.Clinical PresentationAsymptomatic cases: In some instances, myocarditis may be asymptomatic, with the infection resolving without intervention. These cases often go undetected unless discovered incidentally through diagnostic imaging or tests conducted for other reasons.General Early Symptoms: Early symptoms of myocarditis are non-specific and can...